ZYUS Life Sciences Corporation (TSXV: ZYUS)
Canada
· Delayed Price · Currency is CAD
0.830
-0.020 (-2.35%)
Dec 20, 2024, 10:22 AM EST
ZYUS Life Sciences Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Sep '24 Sep 29, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 30, 2021 | Dec '20 Dec 30, 2020 |
Cash & Equivalents | 0.35 | 3.98 | 0.21 | 0.75 | 7.99 |
Short-Term Investments | - | 1.87 | - | - | - |
Cash & Short-Term Investments | 0.35 | 5.85 | 0.21 | 0.75 | 7.99 |
Cash Growth | -96.20% | 2660.38% | -71.73% | -90.62% | - |
Accounts Receivable | 0.41 | 0.16 | 0.2 | 0.02 | 0.01 |
Other Receivables | - | 0.47 | 0.04 | 0.33 | 0.66 |
Receivables | 0.41 | 0.63 | 0.24 | 0.35 | 0.68 |
Inventory | 1.96 | 2.04 | 4.2 | 5.08 | 4.91 |
Prepaid Expenses | 0.77 | 0.31 | 0.86 | 0.91 | 1.4 |
Other Current Assets | - | 0.56 | 0.75 | 0.43 | 0.03 |
Total Current Assets | 3.48 | 9.39 | 6.27 | 7.52 | 15.01 |
Property, Plant & Equipment | 11.94 | 13.89 | 17.03 | 20.51 | 17.43 |
Goodwill | 5.87 | 5.87 | 5.87 | 5.87 | 5.87 |
Other Intangible Assets | 12.54 | 12.32 | 35.39 | 36.24 | 37.68 |
Other Long-Term Assets | 0.15 | 0.15 | 0.16 | 0.16 | 0.15 |
Total Assets | 33.98 | 41.63 | 64.71 | 70.29 | 76.14 |
Accounts Payable | 9.14 | 3.44 | 8.51 | 5.68 | 3.8 |
Accrued Expenses | - | 3.26 | 4.53 | 3.61 | 2.36 |
Short-Term Debt | 0.43 | - | 0.9 | - | - |
Current Portion of Long-Term Debt | 4.3 | 6.15 | 0 | - | - |
Current Portion of Leases | 0.43 | 0.4 | 0.33 | 0.38 | 0.24 |
Total Current Liabilities | 14.3 | 13.24 | 14.27 | 9.67 | 6.4 |
Long-Term Debt | 0.43 | 0.64 | 30.8 | 22.05 | 10.98 |
Long-Term Leases | 2.36 | 2.62 | 2.88 | 3.21 | 3.04 |
Long-Term Deferred Tax Liabilities | 2.01 | 2.02 | 8.05 | 7.6 | 7.75 |
Other Long-Term Liabilities | - | - | 3.98 | 2.59 | 3.96 |
Total Liabilities | 19.09 | 18.51 | 59.97 | 45.1 | 32.12 |
Common Stock | 156.7 | 154.09 | 92.67 | 78.05 | 72.74 |
Additional Paid-In Capital | 5.72 | 5.39 | 5.63 | 19.97 | 19.36 |
Retained Earnings | -152.26 | -140.19 | -97.6 | -72.94 | -49.48 |
Comprehensive Income & Other | 4.73 | 3.82 | 4.04 | 0.11 | 1.4 |
Shareholders' Equity | 14.89 | 23.11 | 4.74 | 25.19 | 44.02 |
Total Liabilities & Equity | 33.98 | 41.63 | 64.71 | 70.29 | 76.14 |
Total Debt | 7.94 | 9.81 | 34.9 | 25.64 | 14.26 |
Net Cash (Debt) | -7.6 | -3.95 | -34.69 | -24.89 | -6.26 |
Net Cash Per Share | -0.11 | -0.07 | -0.90 | -0.49 | -0.13 |
Filing Date Shares Outstanding | 74.36 | 70.85 | 54.7 | 51.81 | 48.7 |
Total Common Shares Outstanding | 74.36 | 70.85 | 54.7 | 51.81 | 48.7 |
Working Capital | -10.82 | -3.86 | -8 | -2.15 | 8.6 |
Book Value Per Share | 0.20 | 0.33 | 0.09 | 0.49 | 0.90 |
Tangible Book Value | -3.52 | 4.92 | -36.52 | -16.92 | 0.47 |
Tangible Book Value Per Share | -0.05 | 0.07 | -0.67 | -0.33 | 0.01 |
Land | - | - | - | 0.88 | 0.88 |
Machinery | - | 1.71 | 1.7 | 10.74 | 9.24 |
Construction In Progress | - | 10.85 | 10.77 | 1.31 | 1.73 |
Leasehold Improvements | - | 10.7 | 10.51 | 10.48 | 6.59 |
Source: S&P Capital IQ. Standard template. Financial Sources.